Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$16.80
-4.35-20.57%
At close: -
$16.80
0.000.00%
After Hours: May 16, 7:20 PM EDT
Comments
Loading...
Travere Therapeutics Stock Price, Quotes and Forecasts
TVTXNASDAQ
Travere Therapeutics (TVTX) Forecast
NewsEarningsTravere Therapeutics (TVTX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Travere Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:TVTX | Benzinga
Explore Travere Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for TVTX.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Travere Therapeutics (TVTX) stock?
You can purchase shares of Travere Therapeutics (NASDAQ:TVTX) through any online brokerage.
Who are Travere Therapeutics (TVTX) competitors?
Other companies in Travere Therapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), Centessa Pharmaceuticals (NASDAQ:CNTA), Ascentage Pharma Group (NASDAQ:AAPG) and Arcutis Biotherapeutics (NASDAQ:ARQT).
What is the forecast, or price target, for Travere Therapeutics (TVTX) stock?
Travere Therapeutics has a consensus price target of $32.53.
What is the current price for Travere Therapeutics (TVTX)?
The stock price for Travere Therapeutics (NASDAQ: TVTX) is $16.8 last updated May 16, 2025 at 7:20 PM EDT.
Does Travere Therapeutics (TVTX) pay a dividend?
There are no upcoming dividends for Travere Therapeutics.
When is Travere Therapeutics (NASDAQ:TVTX) reporting earnings?
Travere Therapeutics’s Q2 earnings are confirmed for Thursday, July 31, 2025.
Is Travere Therapeutics (TVTX) going to split?
There is no upcoming split for Travere Therapeutics.
What sector and industry does Travere Therapeutics (TVTX) operate in?
Travere Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
